SlideShare uma empresa Scribd logo
1 de 39
Antifungal medication
Dr Ilham Sayed
Clinical pharmacist
Introduction
• An antifungal medication is a pharmaceutical
fungicide used to treat mycoses such as
athlete's foot, ringworm, candidiasis (thrush),
serious systemic infections such as
cryptococcal meningitis, and others.
• Such drugs are usually obtained by a doctor's
prescription or purchased over-the-counter.
Classes
• Polyene antifungals
• The polyene antimycotics bind with sterols in the fungal
cell membrane, principally ergosterol.
• This changes the transition temperature (Tg) of the cell
membrane, thereby placing the membrane in a less fluid,
more crystalline state. (In ordinary circumstances
membrane sterols increase the packing of the phospholipid
bilayer making the plasma membrane more dense.)
• As a result, the cell's contents including monovalent ions
(K+, Na+, H+, and Cl-), small organic molecules leak and this
is regarded one of the primary ways cell dies.
• Amphotericin B
• Candicidin
• Natamycin
• Nystatin
• Rimocidin
Imidazole, triazole, and thiazole
antifungals
• Azole antifungal drugs inhibit the enzyme
lanosterol 14 α-demethylase; the enzyme
necessary to convert lanosterol to ergosterol.
• Depletion of ergosterol in fungal membrane
disrupts the structure and many functions of
fungal membrane leading to inhibition of
fungal growth.
Imidazoles
• Clotrimazole
• Econazole
• Ketoconazole
• Miconazole.
• Triazoles
• Albaconazole
• Fluconazole
• Itraconazole
Thiazoles
• Abafungin.
• Allylamines
• Allylamines inhibit squalene epoxidase, another
enzyme required for ergosterol synthesis:
• Amorolfin
• Butenafine
• Naftifine
• Terbinafine
Echinocandins
• Echinocandins may be used for systemic fungal
infections in immunocompromised patients, they
inhibit the synthesis of glucan in the cell wall via the
enzyme 1,3-β glucan synthase:
• Anidulafungin
• Caspofungin
• Micafungin
• Echinocandins are poorly absorbed when administered
orally.
• When administered by injection they will reach most
tissues and organs with concentrations sufficient to
treat localized and systemic fungal infections.
Others
• Benzoic acid – has antifugal properties, but must be combined with a
keratolytic agent such as in Whitfield's ointment
• Ciclopirox – (ciclopirox olamine) – is a hydroxypyridone antifungal which
interferes with active membrane transport, cell membrane integrity, and
fungal respiratory processes. It is most useful against tinea versicolour.
• Flucytosine or 5-fluorocytosine – an antimetabolite pyrimidine analog
• Griseofulvin – binds to polymerized microtubules and inhibits fungal
mitosis
• Polygodial – strong and fast-acting in-vitroantifungal activity against
Candida albicans.
• Tolnaftate – a thiocarbamate antifungal, which inhibits fungal squalene
epoxidase (similar mechanism to allylamines like terbinafine)
• Undecylenic acid – an unsaturated fatty acid derived from natural castor
oil; fungistatic, antibacterial, antiviral, and inhibits Candida
morphogenesis
• Crystal violet – a triarylmethane dye, it has antibacterial, antifungal, and
anthelmintic properties and was formerly important as a topical
antiseptic.
Adverse effects
Apart from side effects like liver damage or
affecting estrogen levels, many antifungal
medicines can cause allergic reactions in
people.
For example, the azole group of drugs is known
to have caused anaphylaxis.
Drug interactions
• There are also many drug interactions.
• For example, the azole antifungals such as ketoconazole or
itraconazole can be both substrates and inhibitors of the
P-glycoprotein, which (among other functions) excretes
toxins and drugs into the intestines.
• Azole antifungals also are both substrates and inhibitors of
the cytochrome P450 family CYP3A4, causing increased
concentration when administering, for example,
calcium channel blockers, immunosuppressants,
chemotherapeutic drugs, benzodiazepines, tricyclic
antidepressants, macrolides and SSRIs.
Antiviral drug
• Antiviral drugs are a class of medication used
specifically for treating viral infections.
• Unlike most antibiotics, antiviral drugs do not destroy
their target pathogen; instead they inhibit their
development.
• Most of the antiviral drugs now available are designed
to help deal with HIV, herpes viruses (best known for
causing cold sores and genital herpes, but actually the
cause of a wide range of other diseases, such as
chicken pox), the hepatitis B and C viruses, which can
cause liver cancer, and influenza A and B viruses.
• Virus is a nucleic acid, either DNA or RNA which is
infectious in nature.
• Virus can infect all kind of organisms including plants,
animals and bacteria.
• This nucleic strand of the DNA is called genome.
Outside genome there is covering of proteinaceous
coat called capsid.
• Outside the capsid there presents a fatty envelope.
Capsid and genome together is known as nucleocapsid
and all the three capsid, genome and envelope
together is known as virion.
• Virus is an obligate parasite i.e. active only inside the
host cells.
• Viruses are parasites that cannot reproduce on their
own.
• They recognize specific molecules on the surface of
target cells and bind to them.
• After entering the cells, viruses take off their protein
coat'a process called un-coating'to release the genome
(DNA or RNA).
• They use the host cell's tools to reproduce themselves.
• Released viruses find new host cells to infect.
• Antiviral medications prevent viral entry, un-coating,
replication of viral genome (DNA or RNA), re-coating
and spread of viruses to new host cells.
Classes
• Antiviral drugs are classified into following classes:-
• a) Anti-herpes virus- Acyclovir, Gancyclovir,
Idoxuridine& Foscarnent.
• b) Anti-influenza virus- Amantadine & Rimantadine
• c) Broad spectrum antivral drugs- Vidabarine &
Ribavarine
• d) Anti-HIV virus- Stavudine, Zidovudine, Carbovir &
Didanosine
• e) Anti-small pox virus- Methisazone & Anildone
Actions
• Nucleoside-Analog Reverse Transcriptase
Inhibitors (NRTI). These drugs inhibit viral RNA-
dependent DNA polymerase (reverse
transcriptase) and are incorporated into viral
DNA (they are chain-terminating drugs).
– Zidovudine (AZT = ZDV, Retrovir) first approved in
1987
– Didanosine
– Zalcitabine
– Stavudine
_ Lamivudine
Non-Nucleoside Reverse
Transcriptase Inhibitors (NNRTIs)
• In contrast to NRTIs, NNRTIs are not incorporated into viral
DNA; they inhibit HIV replication directly by binding non-
competitively to reverse transcriptase.
– Nevirapine
– Delavirdine
• Protease Inhibitors. These drugs are specific for the HIV-1
protease and competitively inhibit the enzyme, preventing
the maturation of virions capable of infecting other cells.
– Saquinavir - first approved in 1995
– Ritonavir
– Indinavir
– Nelfinavir
Side effects
• Anemia
• ii) Granulocytopenia
• iii) Thrombocytopenia
• Bronchospasm
• GI upset and headache
• Renal dysfunction
Limitations of vaccines
• Vaccines bolster the body's immune system to better attack viruses
in the "complete particle" stage, outside of the organism's cells.
• They traditionally consist of an attenuated (a live weakened) or
inactivated (killed) version of the virus.
• These vaccines can, in rare cases, harm the host by inadvertently
infecting the host with a full-blown viral occupancy.
• Recently "subunit" vaccines have been devised that consist strictly
of protein targets from the pathogen. They stimulate the
immune system without doing serious harm to the host. In either
case, when the real pathogen attacks the subject, the immune
system responds to it quickly and blocks it.
• Vaccines are very effective on stable viruses, but are of limited use
in treating a patient who has already been infected. They are also
difficult to successfully deploy against rapidly mutating viruses,
such as influenza (the vaccine for which is updated every year) and
HIV. Antiviral drugs are particularly useful in these cases.
• Entry inhibitor
• A very early stage of viral infection is viral entry,
when the virus attaches to and enters the host cell. A
number of "entry-inhibiting" or "entry-blocking"
drugs are being developed to fight HIV.
• HIV most heavily targets the immune system's white
blood cells known as "helper T cells", and identifies
these target cells through T-cell surface receptors
designated "CD4" and "CCR5". Attempts to interfere
with the binding of HIV with the CD4 receptor have
failed to stop HIV from infecting helper T cells, but
research continues on trying to interfere with the
binding of HIV to the CCR5 receptor in hopes that it
will be more effective.
• Reverse transcription
• One way of doing this is to develop nucleotide or nucleoside
analogues that look like the building blocks of RNA or DNA,
but deactivate the enzymes that synthesize the RNA or DNA
once the analogue is incorporated. This approach is more
commonly associated with the inhibition of reverse
transcriptase (RNA to DNA) than with "normal" transcriptase
(DNA to RNA).
• The first antiviral drug to be approved for treating HIV,
zidovudine (AZT), is also a nucleoside analogue.
• An improved knowledge of the action of reverse transcriptase
has led to better nucleoside analogues to treat HIV infections.
• Researchers have gone further and developed inhibitors that
do not look like nucleosides, but can still block reverse
transcriptase.
• Another target being considered for HIV antivirals include
RNase H – which is a component of reverse transcriptase that
splits the synthesized DNA from the original viral RNA .
Analgesics, Anti-inflammatory-
Antipyretics
Analgesia
• An analgesic, or painkiller, is any member of the
group of drugs used to achieve analgesia — relief
from pain.
• Analgesic drugs act in various ways on the peripheral
and central nervous systems.
• They are distinct from anesthetics, which reversibly
eliminate sensation.
• Classes: 1_ paracetamol (known in the US as
acetaminophen).
2_ The non-steroidal anti-inflammatory drugs (NSAIDs)
such as the salicylates, and
3_ Opioid drugs such as morphine and opium.
Major classes
• Paracetamol and NSAIDs:
• The exact mechanism of action of
paracetamol/acetaminophen is uncertain but
appears to act centrally in the brain rather than
peripherally in nerve endings.
• Aspirin and the other non-steroidal anti-
inflammatory drugs (NSAIDs) inhibit
cyclooxygenases, leading to a decrease in
prostaglandin production.
• In contrast to paracetamol and the opioids, this not
only reduces pain but inflammation as well.
Side effects
• Paracetamol has few side effects and is regarded as
generally safe, although excess or sustained use can
lead to potentially life-threatening liver damage and
occasionally kidney damage.
• While paracetamol is usually taken orally or rectally,
an intravenous preparation introduced in 2002 has
been shown to improve pain relief and reduce opioid
consumption in the postoperative setting.
• NSAIDs predispose to peptic ulcers, renal
failure, allergic reactions, and
• Occasionally hearing loss, and they can
increase the risk of hemorrhage by affecting
platelet function.
• The use of aspirin in children under 16
suffering from viral illness has been linked to
Reye's syndrome, a rare but severe liver
disorder.
COX-2 inhibitors
• These drugs have been derived from NSAIDs.
• The cyclooxygenase enzyme inhibited by
NSAIDs was discovered to have at least 2
different versions: COX1 and COX2.
• Research suggested that most of the adverse
effects of NSAIDs were mediated by blocking
the COX1 enzyme, with the analgesic effects
being mediated by the COX2 enzyme.
• The COX2 inhibitors were thus developed to inhibit
only the COX2 enzyme (traditional NSAIDs block both
versions in general).
• These drugs (such as rofecoxib, celecoxib and
etoricoxib) are equally effective analgesics when
compared with NSAIDs, but cause less
gastrointestinal hemorrhage in particular.
• After widespread adoption of the COX-2 inhibitors, it
was discovered that most of the drugs in this class
increased the risk of cardiovascular events by 40% on
average.
• This led to the withdrawal of rofecoxib and
valdecoxib, and warnings on others.
• Etoricoxib seems relatively safe, with the risk of
thrombotic events similar to that of non-coxib NSAID
diclofenac.
Opioids and Opiates
• Morphine, and various other substances (e.g.
codeine, oxycodone, hydrocodone,
dihydromorphine, pethidine) all exert a similar
influence on the cerebral opioid receptor
system.
• Buprenorphine is thought to be a partial
agonist of the opioid receptor, and tramadol is
an opiate agonist.
• Tramadol is delivers analgesia by not only
delivering "opiate-like" effects (through mild
agonism of the mu receptor) but also by
acting as a weak but fast-acting serotonin
releasing agent and norepinephrine reuptake
inhibitor.
• Dosing of all opioids may be limited by opioid
toxicity (confusion, respiratory depression,
myoclonic jerks and pinpoint pupils), seizures (
tramadol), but there is no dose ceiling in
patients who accumulate tolerance.
Side effects
• Opioids, while very effective analgesics, may
have some unpleasant side-effects.
• Patients starting morphine may experience
nausea and vomiting (generally relieved by a
short course of antiemetics such as
phenergan).
• Pruritus (itching) may require switching to a
different opioid.
• Constipation occurs in almost all patients on
opioids, and laxatives co-prescribed.
• When used appropriately, opioids and similar
narcotic analgesics are otherwise safe and
effective, however risks such as addiction and
the body becoming used to the drug
(tolerance) can occur.
• The effect of tolerance means that frequent
use of the drug may result in its diminished
effect so, when safe to do so, the dosage may
need to be increased to maintain
effectiveness.
• This may be of particular concern regarding
patients suffering with chronic pain.
Specific agents
• In patients with chronic or neuropathic pain, various
other substances may have analgesic properties.
• Tricyclic antidepressants, especially amitriptyline,
have been shown to improve pain in what appears to
be a central manner.
• Nefopam is used in Europe for pain relief with
concurrent opioids.
• The exact mechanism of carbamazepine, gabapentin
and pregabalin is similarly unclear, but these
anticonvulsants are used to treat neuropathic pain
with differing degrees of success.
• Anticonvulsants are most commonly used for
neuropathic pain as their mechanism of action tends
to inhibit pain sensation.
Anti-inflammatory
• Anti-inflammatory refers to the property of a
substance or treatment that reduces
inflammation.
• Anti-inflammatory drugs make up about half
of analgesics, remedying pain by reducing
inflammation as opposed to opioids, which
affect the central nervous system.
Classes
• Steroids Many steroids, to be specific
glucocorticoids, reduce inflammation or
swelling by binding to glucocorticoid
receptors.
• These drugs are often referred to as
corticosteroids.
Non-steroidal anti-inflammatory
drugs
• Non-steroidal anti-inflammatory drugs (NSAIDs),
alleviate pain by counteracting the cyclooxygenase
(COX) enzyme.
• On its own, COX enzyme synthesizes prostaglandins,
creating inflammation. In whole, the NSAIDs prevent
the prostaglandins from ever being synthesized,
reducing or eliminating the pain.
• Some common examples of NSAIDs are: aspirin,
ibuprofen, and naproxen.
• The newer specific COX-inhibitors - it is presumed,
sharing a similar mode of action - are not classified
together with the traditional NSAIDs.
• On the other hand, there are analgesics that are
commonly associated with anti-inflammatory drugs
but that have no anti-inflammatory effects.
• An example is paracetamol, As opposed to NSAIDs,
which reduce pain and inflammation by inhibiting
COX enzymes, paracetamol has recently been shown
to block the reuptake of endocannabinoids, which
only reduces pain, likely explaining why it has
minimal effect on inflammation
Antipyretic
• Antipyretics are drugs or herbs that reduce fever.
• Antipyretics cause the hypothalamus to override an
interleukin-induced increase in temperature.
• The body then works to lower the temperature,
resulting in a reduction in fever.
• Most antipyretic medications have other purposes.
• The most common antipyretics are ibuprofen and
aspirin, which are used primarily as pain relievers.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are
antipyretic, anti-inflammatory, and pain relievers.

Mais conteúdo relacionado

Mais procurados

Anti viral drugs of medicinal chemistry
Anti viral drugs of medicinal chemistryAnti viral drugs of medicinal chemistry
Anti viral drugs of medicinal chemistryPranjal Saxena
 
Introduction to tetracyclines and quinolones
Introduction to tetracyclines and quinolonesIntroduction to tetracyclines and quinolones
Introduction to tetracyclines and quinolonesTareq ✅
 
Antiviral HIV ARVS AIDS RETROVIRAL
Antiviral HIV ARVS AIDS RETROVIRALAntiviral HIV ARVS AIDS RETROVIRAL
Antiviral HIV ARVS AIDS RETROVIRALLarry Mweetwa
 
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolonesMirza Anwar Baig
 
Anti-Virals Drugs (Medicinal Chemistry)
Anti-Virals Drugs (Medicinal Chemistry)Anti-Virals Drugs (Medicinal Chemistry)
Anti-Virals Drugs (Medicinal Chemistry)Faizan Akram
 
Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents Soujanya Pharm.D
 
Newly Discovered Antiviral Drugs
Newly Discovered Antiviral DrugsNewly Discovered Antiviral Drugs
Newly Discovered Antiviral DrugsAbera Dessie
 
Quinolones. Antiviral drugs
Quinolones. Antiviral drugsQuinolones. Antiviral drugs
Quinolones. Antiviral drugsEneutron
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
FluoroquinolonesZainab&Sons
 
Antifungal and Antiviral Agents
Antifungal and Antiviral AgentsAntifungal and Antiviral Agents
Antifungal and Antiviral AgentsA. Rakha
 
Antiviral agents history, classification,mechanism of action and adverse effect
Antiviral agents history, classification,mechanism of action and adverse effectAntiviral agents history, classification,mechanism of action and adverse effect
Antiviral agents history, classification,mechanism of action and adverse effectMuhammad Amir Sohail
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugsCCRMHZN
 

Mais procurados (20)

Anti viral drugs of medicinal chemistry
Anti viral drugs of medicinal chemistryAnti viral drugs of medicinal chemistry
Anti viral drugs of medicinal chemistry
 
Introduction to tetracyclines and quinolones
Introduction to tetracyclines and quinolonesIntroduction to tetracyclines and quinolones
Introduction to tetracyclines and quinolones
 
Antiviral HIV ARVS AIDS RETROVIRAL
Antiviral HIV ARVS AIDS RETROVIRALAntiviral HIV ARVS AIDS RETROVIRAL
Antiviral HIV ARVS AIDS RETROVIRAL
 
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
 
Acyclovir
AcyclovirAcyclovir
Acyclovir
 
Antiviral Agents
Antiviral AgentsAntiviral Agents
Antiviral Agents
 
Anti-Virals Drugs (Medicinal Chemistry)
Anti-Virals Drugs (Medicinal Chemistry)Anti-Virals Drugs (Medicinal Chemistry)
Anti-Virals Drugs (Medicinal Chemistry)
 
Anti tuberculosis Agents
Anti tuberculosis AgentsAnti tuberculosis Agents
Anti tuberculosis Agents
 
Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents
 
Antiviral
AntiviralAntiviral
Antiviral
 
Newly Discovered Antiviral Drugs
Newly Discovered Antiviral DrugsNewly Discovered Antiviral Drugs
Newly Discovered Antiviral Drugs
 
Quinolones. Antiviral drugs
Quinolones. Antiviral drugsQuinolones. Antiviral drugs
Quinolones. Antiviral drugs
 
Antiviral 1
Antiviral 1Antiviral 1
Antiviral 1
 
Antivirals
AntiviralsAntivirals
Antivirals
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
Antifungal and Antiviral Agents
Antifungal and Antiviral AgentsAntifungal and Antiviral Agents
Antifungal and Antiviral Agents
 
Antiviral agents history, classification,mechanism of action and adverse effect
Antiviral agents history, classification,mechanism of action and adverse effectAntiviral agents history, classification,mechanism of action and adverse effect
Antiviral agents history, classification,mechanism of action and adverse effect
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Quinolones & Fluoroquinolones
Quinolones & FluoroquinolonesQuinolones & Fluoroquinolones
Quinolones & Fluoroquinolones
 

Semelhante a Analgesia

pathogensis of HIV.pptx
pathogensis of HIV.pptxpathogensis of HIV.pptx
pathogensis of HIV.pptxDigambarShete
 
HIV (human immunodeficiency virus)
HIV (human immunodeficiency virus)HIV (human immunodeficiency virus)
HIV (human immunodeficiency virus)Aakankshayadav16
 
medicinal chemistry of Antiviral drugs
medicinal chemistry of Antiviral drugsmedicinal chemistry of Antiviral drugs
medicinal chemistry of Antiviral drugsFatenAlsadek
 
Anti retroviral agents (ar vs) for midwives
Anti retroviral agents (ar vs) for midwivesAnti retroviral agents (ar vs) for midwives
Anti retroviral agents (ar vs) for midwivesMesfin Mulugeta
 
Antiviral Drugs, Vaccines and Gene Therapy
Antiviral Drugs, Vaccines and Gene TherapyAntiviral Drugs, Vaccines and Gene Therapy
Antiviral Drugs, Vaccines and Gene TherapyBiakhan72
 
Management of HIV(proper)
Management of HIV(proper)Management of HIV(proper)
Management of HIV(proper)Gagandeep Gauba
 
Antiviral Agents
Antiviral Agents Antiviral Agents
Antiviral Agents Dr Htet
 
OCR F222 module 3
OCR F222 module 3OCR F222 module 3
OCR F222 module 3JenBash
 
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptx
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptxEtiology, pathophysiology, Pharmacotherapy of AIDS .pptx
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptxdrsriram2001
 
Chemotherapy of HIV/AIDS
Chemotherapy of HIV/AIDSChemotherapy of HIV/AIDS
Chemotherapy of HIV/AIDSPriyansha Singh
 
A Presentation on Virus and Anti-Viral Therapy
A Presentation on Virus and Anti-Viral TherapyA Presentation on Virus and Anti-Viral Therapy
A Presentation on Virus and Anti-Viral TherapyGagandeep Jaiswal
 
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)Naveen K L
 

Semelhante a Analgesia (20)

AIDS
AIDSAIDS
AIDS
 
Mayank.pptx
Mayank.pptxMayank.pptx
Mayank.pptx
 
Chapter05
Chapter05Chapter05
Chapter05
 
pathogensis of HIV.pptx
pathogensis of HIV.pptxpathogensis of HIV.pptx
pathogensis of HIV.pptx
 
ANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.pptANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.ppt
 
AMA-_Antiviral_drugs.pdf
AMA-_Antiviral_drugs.pdfAMA-_Antiviral_drugs.pdf
AMA-_Antiviral_drugs.pdf
 
HIV (human immunodeficiency virus)
HIV (human immunodeficiency virus)HIV (human immunodeficiency virus)
HIV (human immunodeficiency virus)
 
Anti viral
Anti viralAnti viral
Anti viral
 
medicinal chemistry of Antiviral drugs
medicinal chemistry of Antiviral drugsmedicinal chemistry of Antiviral drugs
medicinal chemistry of Antiviral drugs
 
Antiviraldrugs
AntiviraldrugsAntiviraldrugs
Antiviraldrugs
 
Anti retroviral agents (ar vs) for midwives
Anti retroviral agents (ar vs) for midwivesAnti retroviral agents (ar vs) for midwives
Anti retroviral agents (ar vs) for midwives
 
Antiviral Drugs, Vaccines and Gene Therapy
Antiviral Drugs, Vaccines and Gene TherapyAntiviral Drugs, Vaccines and Gene Therapy
Antiviral Drugs, Vaccines and Gene Therapy
 
Management of HIV(proper)
Management of HIV(proper)Management of HIV(proper)
Management of HIV(proper)
 
Antiviral Agents
Antiviral Agents Antiviral Agents
Antiviral Agents
 
OCR F222 module 3
OCR F222 module 3OCR F222 module 3
OCR F222 module 3
 
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptx
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptxEtiology, pathophysiology, Pharmacotherapy of AIDS .pptx
Etiology, pathophysiology, Pharmacotherapy of AIDS .pptx
 
Chemotherapy of HIV/AIDS
Chemotherapy of HIV/AIDSChemotherapy of HIV/AIDS
Chemotherapy of HIV/AIDS
 
A Presentation on Virus and Anti-Viral Therapy
A Presentation on Virus and Anti-Viral TherapyA Presentation on Virus and Anti-Viral Therapy
A Presentation on Virus and Anti-Viral Therapy
 
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)
SlideShare On Chemotherapy of Antiviral Drugs (Pharmacology)
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 

Último

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Vector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesVector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesZilliz
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
The Future of Software Development - Devin AI Innovative Approach.pdf
The Future of Software Development - Devin AI Innovative Approach.pdfThe Future of Software Development - Devin AI Innovative Approach.pdf
The Future of Software Development - Devin AI Innovative Approach.pdfSeasiaInfotech2
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024The Digital Insurer
 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Manik S Magar
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfRankYa
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Commit University
 
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)Bun (KitWorks Team Study 노별마루 발표 2024.4.22)
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)Wonjun Hwang
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Mattias Andersson
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 

Último (20)

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Vector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesVector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector Databases
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
The Future of Software Development - Devin AI Innovative Approach.pdf
The Future of Software Development - Devin AI Innovative Approach.pdfThe Future of Software Development - Devin AI Innovative Approach.pdf
The Future of Software Development - Devin AI Innovative Approach.pdf
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024
 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdf
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!
 
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)Bun (KitWorks Team Study 노별마루 발표 2024.4.22)
Bun (KitWorks Team Study 노별마루 발표 2024.4.22)
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 

Analgesia

  • 1. Antifungal medication Dr Ilham Sayed Clinical pharmacist
  • 2. Introduction • An antifungal medication is a pharmaceutical fungicide used to treat mycoses such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. • Such drugs are usually obtained by a doctor's prescription or purchased over-the-counter.
  • 3. Classes • Polyene antifungals • The polyene antimycotics bind with sterols in the fungal cell membrane, principally ergosterol. • This changes the transition temperature (Tg) of the cell membrane, thereby placing the membrane in a less fluid, more crystalline state. (In ordinary circumstances membrane sterols increase the packing of the phospholipid bilayer making the plasma membrane more dense.) • As a result, the cell's contents including monovalent ions (K+, Na+, H+, and Cl-), small organic molecules leak and this is regarded one of the primary ways cell dies.
  • 4. • Amphotericin B • Candicidin • Natamycin • Nystatin • Rimocidin
  • 5. Imidazole, triazole, and thiazole antifungals • Azole antifungal drugs inhibit the enzyme lanosterol 14 α-demethylase; the enzyme necessary to convert lanosterol to ergosterol. • Depletion of ergosterol in fungal membrane disrupts the structure and many functions of fungal membrane leading to inhibition of fungal growth.
  • 6. Imidazoles • Clotrimazole • Econazole • Ketoconazole • Miconazole. • Triazoles • Albaconazole • Fluconazole • Itraconazole
  • 7. Thiazoles • Abafungin. • Allylamines • Allylamines inhibit squalene epoxidase, another enzyme required for ergosterol synthesis: • Amorolfin • Butenafine • Naftifine • Terbinafine
  • 8. Echinocandins • Echinocandins may be used for systemic fungal infections in immunocompromised patients, they inhibit the synthesis of glucan in the cell wall via the enzyme 1,3-β glucan synthase: • Anidulafungin • Caspofungin • Micafungin • Echinocandins are poorly absorbed when administered orally. • When administered by injection they will reach most tissues and organs with concentrations sufficient to treat localized and systemic fungal infections.
  • 9. Others • Benzoic acid – has antifugal properties, but must be combined with a keratolytic agent such as in Whitfield's ointment • Ciclopirox – (ciclopirox olamine) – is a hydroxypyridone antifungal which interferes with active membrane transport, cell membrane integrity, and fungal respiratory processes. It is most useful against tinea versicolour. • Flucytosine or 5-fluorocytosine – an antimetabolite pyrimidine analog • Griseofulvin – binds to polymerized microtubules and inhibits fungal mitosis • Polygodial – strong and fast-acting in-vitroantifungal activity against Candida albicans. • Tolnaftate – a thiocarbamate antifungal, which inhibits fungal squalene epoxidase (similar mechanism to allylamines like terbinafine) • Undecylenic acid – an unsaturated fatty acid derived from natural castor oil; fungistatic, antibacterial, antiviral, and inhibits Candida morphogenesis • Crystal violet – a triarylmethane dye, it has antibacterial, antifungal, and anthelmintic properties and was formerly important as a topical antiseptic.
  • 10. Adverse effects Apart from side effects like liver damage or affecting estrogen levels, many antifungal medicines can cause allergic reactions in people. For example, the azole group of drugs is known to have caused anaphylaxis.
  • 11. Drug interactions • There are also many drug interactions. • For example, the azole antifungals such as ketoconazole or itraconazole can be both substrates and inhibitors of the P-glycoprotein, which (among other functions) excretes toxins and drugs into the intestines. • Azole antifungals also are both substrates and inhibitors of the cytochrome P450 family CYP3A4, causing increased concentration when administering, for example, calcium channel blockers, immunosuppressants, chemotherapeutic drugs, benzodiazepines, tricyclic antidepressants, macrolides and SSRIs.
  • 12. Antiviral drug • Antiviral drugs are a class of medication used specifically for treating viral infections. • Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development. • Most of the antiviral drugs now available are designed to help deal with HIV, herpes viruses (best known for causing cold sores and genital herpes, but actually the cause of a wide range of other diseases, such as chicken pox), the hepatitis B and C viruses, which can cause liver cancer, and influenza A and B viruses.
  • 13.
  • 14. • Virus is a nucleic acid, either DNA or RNA which is infectious in nature. • Virus can infect all kind of organisms including plants, animals and bacteria. • This nucleic strand of the DNA is called genome. Outside genome there is covering of proteinaceous coat called capsid. • Outside the capsid there presents a fatty envelope. Capsid and genome together is known as nucleocapsid and all the three capsid, genome and envelope together is known as virion. • Virus is an obligate parasite i.e. active only inside the host cells.
  • 15. • Viruses are parasites that cannot reproduce on their own. • They recognize specific molecules on the surface of target cells and bind to them. • After entering the cells, viruses take off their protein coat'a process called un-coating'to release the genome (DNA or RNA). • They use the host cell's tools to reproduce themselves. • Released viruses find new host cells to infect. • Antiviral medications prevent viral entry, un-coating, replication of viral genome (DNA or RNA), re-coating and spread of viruses to new host cells.
  • 16. Classes • Antiviral drugs are classified into following classes:- • a) Anti-herpes virus- Acyclovir, Gancyclovir, Idoxuridine& Foscarnent. • b) Anti-influenza virus- Amantadine & Rimantadine • c) Broad spectrum antivral drugs- Vidabarine & Ribavarine • d) Anti-HIV virus- Stavudine, Zidovudine, Carbovir & Didanosine • e) Anti-small pox virus- Methisazone & Anildone
  • 17. Actions • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTI). These drugs inhibit viral RNA- dependent DNA polymerase (reverse transcriptase) and are incorporated into viral DNA (they are chain-terminating drugs). – Zidovudine (AZT = ZDV, Retrovir) first approved in 1987 – Didanosine – Zalcitabine – Stavudine _ Lamivudine
  • 18. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) • In contrast to NRTIs, NNRTIs are not incorporated into viral DNA; they inhibit HIV replication directly by binding non- competitively to reverse transcriptase. – Nevirapine – Delavirdine • Protease Inhibitors. These drugs are specific for the HIV-1 protease and competitively inhibit the enzyme, preventing the maturation of virions capable of infecting other cells. – Saquinavir - first approved in 1995 – Ritonavir – Indinavir – Nelfinavir
  • 19. Side effects • Anemia • ii) Granulocytopenia • iii) Thrombocytopenia • Bronchospasm • GI upset and headache • Renal dysfunction
  • 20. Limitations of vaccines • Vaccines bolster the body's immune system to better attack viruses in the "complete particle" stage, outside of the organism's cells. • They traditionally consist of an attenuated (a live weakened) or inactivated (killed) version of the virus. • These vaccines can, in rare cases, harm the host by inadvertently infecting the host with a full-blown viral occupancy. • Recently "subunit" vaccines have been devised that consist strictly of protein targets from the pathogen. They stimulate the immune system without doing serious harm to the host. In either case, when the real pathogen attacks the subject, the immune system responds to it quickly and blocks it. • Vaccines are very effective on stable viruses, but are of limited use in treating a patient who has already been infected. They are also difficult to successfully deploy against rapidly mutating viruses, such as influenza (the vaccine for which is updated every year) and HIV. Antiviral drugs are particularly useful in these cases.
  • 21. • Entry inhibitor • A very early stage of viral infection is viral entry, when the virus attaches to and enters the host cell. A number of "entry-inhibiting" or "entry-blocking" drugs are being developed to fight HIV. • HIV most heavily targets the immune system's white blood cells known as "helper T cells", and identifies these target cells through T-cell surface receptors designated "CD4" and "CCR5". Attempts to interfere with the binding of HIV with the CD4 receptor have failed to stop HIV from infecting helper T cells, but research continues on trying to interfere with the binding of HIV to the CCR5 receptor in hopes that it will be more effective.
  • 22. • Reverse transcription • One way of doing this is to develop nucleotide or nucleoside analogues that look like the building blocks of RNA or DNA, but deactivate the enzymes that synthesize the RNA or DNA once the analogue is incorporated. This approach is more commonly associated with the inhibition of reverse transcriptase (RNA to DNA) than with "normal" transcriptase (DNA to RNA). • The first antiviral drug to be approved for treating HIV, zidovudine (AZT), is also a nucleoside analogue. • An improved knowledge of the action of reverse transcriptase has led to better nucleoside analogues to treat HIV infections. • Researchers have gone further and developed inhibitors that do not look like nucleosides, but can still block reverse transcriptase. • Another target being considered for HIV antivirals include RNase H – which is a component of reverse transcriptase that splits the synthesized DNA from the original viral RNA .
  • 24. Analgesia • An analgesic, or painkiller, is any member of the group of drugs used to achieve analgesia — relief from pain. • Analgesic drugs act in various ways on the peripheral and central nervous systems. • They are distinct from anesthetics, which reversibly eliminate sensation. • Classes: 1_ paracetamol (known in the US as acetaminophen). 2_ The non-steroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, and 3_ Opioid drugs such as morphine and opium.
  • 25. Major classes • Paracetamol and NSAIDs: • The exact mechanism of action of paracetamol/acetaminophen is uncertain but appears to act centrally in the brain rather than peripherally in nerve endings. • Aspirin and the other non-steroidal anti- inflammatory drugs (NSAIDs) inhibit cyclooxygenases, leading to a decrease in prostaglandin production. • In contrast to paracetamol and the opioids, this not only reduces pain but inflammation as well.
  • 26. Side effects • Paracetamol has few side effects and is regarded as generally safe, although excess or sustained use can lead to potentially life-threatening liver damage and occasionally kidney damage. • While paracetamol is usually taken orally or rectally, an intravenous preparation introduced in 2002 has been shown to improve pain relief and reduce opioid consumption in the postoperative setting.
  • 27. • NSAIDs predispose to peptic ulcers, renal failure, allergic reactions, and • Occasionally hearing loss, and they can increase the risk of hemorrhage by affecting platelet function. • The use of aspirin in children under 16 suffering from viral illness has been linked to Reye's syndrome, a rare but severe liver disorder.
  • 28. COX-2 inhibitors • These drugs have been derived from NSAIDs. • The cyclooxygenase enzyme inhibited by NSAIDs was discovered to have at least 2 different versions: COX1 and COX2. • Research suggested that most of the adverse effects of NSAIDs were mediated by blocking the COX1 enzyme, with the analgesic effects being mediated by the COX2 enzyme.
  • 29. • The COX2 inhibitors were thus developed to inhibit only the COX2 enzyme (traditional NSAIDs block both versions in general). • These drugs (such as rofecoxib, celecoxib and etoricoxib) are equally effective analgesics when compared with NSAIDs, but cause less gastrointestinal hemorrhage in particular. • After widespread adoption of the COX-2 inhibitors, it was discovered that most of the drugs in this class increased the risk of cardiovascular events by 40% on average. • This led to the withdrawal of rofecoxib and valdecoxib, and warnings on others. • Etoricoxib seems relatively safe, with the risk of thrombotic events similar to that of non-coxib NSAID diclofenac.
  • 30. Opioids and Opiates • Morphine, and various other substances (e.g. codeine, oxycodone, hydrocodone, dihydromorphine, pethidine) all exert a similar influence on the cerebral opioid receptor system. • Buprenorphine is thought to be a partial agonist of the opioid receptor, and tramadol is an opiate agonist.
  • 31. • Tramadol is delivers analgesia by not only delivering "opiate-like" effects (through mild agonism of the mu receptor) but also by acting as a weak but fast-acting serotonin releasing agent and norepinephrine reuptake inhibitor. • Dosing of all opioids may be limited by opioid toxicity (confusion, respiratory depression, myoclonic jerks and pinpoint pupils), seizures ( tramadol), but there is no dose ceiling in patients who accumulate tolerance.
  • 32. Side effects • Opioids, while very effective analgesics, may have some unpleasant side-effects. • Patients starting morphine may experience nausea and vomiting (generally relieved by a short course of antiemetics such as phenergan). • Pruritus (itching) may require switching to a different opioid. • Constipation occurs in almost all patients on opioids, and laxatives co-prescribed.
  • 33. • When used appropriately, opioids and similar narcotic analgesics are otherwise safe and effective, however risks such as addiction and the body becoming used to the drug (tolerance) can occur. • The effect of tolerance means that frequent use of the drug may result in its diminished effect so, when safe to do so, the dosage may need to be increased to maintain effectiveness. • This may be of particular concern regarding patients suffering with chronic pain.
  • 34. Specific agents • In patients with chronic or neuropathic pain, various other substances may have analgesic properties. • Tricyclic antidepressants, especially amitriptyline, have been shown to improve pain in what appears to be a central manner. • Nefopam is used in Europe for pain relief with concurrent opioids. • The exact mechanism of carbamazepine, gabapentin and pregabalin is similarly unclear, but these anticonvulsants are used to treat neuropathic pain with differing degrees of success. • Anticonvulsants are most commonly used for neuropathic pain as their mechanism of action tends to inhibit pain sensation.
  • 35. Anti-inflammatory • Anti-inflammatory refers to the property of a substance or treatment that reduces inflammation. • Anti-inflammatory drugs make up about half of analgesics, remedying pain by reducing inflammation as opposed to opioids, which affect the central nervous system.
  • 36. Classes • Steroids Many steroids, to be specific glucocorticoids, reduce inflammation or swelling by binding to glucocorticoid receptors. • These drugs are often referred to as corticosteroids.
  • 37. Non-steroidal anti-inflammatory drugs • Non-steroidal anti-inflammatory drugs (NSAIDs), alleviate pain by counteracting the cyclooxygenase (COX) enzyme. • On its own, COX enzyme synthesizes prostaglandins, creating inflammation. In whole, the NSAIDs prevent the prostaglandins from ever being synthesized, reducing or eliminating the pain. • Some common examples of NSAIDs are: aspirin, ibuprofen, and naproxen. • The newer specific COX-inhibitors - it is presumed, sharing a similar mode of action - are not classified together with the traditional NSAIDs.
  • 38. • On the other hand, there are analgesics that are commonly associated with anti-inflammatory drugs but that have no anti-inflammatory effects. • An example is paracetamol, As opposed to NSAIDs, which reduce pain and inflammation by inhibiting COX enzymes, paracetamol has recently been shown to block the reuptake of endocannabinoids, which only reduces pain, likely explaining why it has minimal effect on inflammation
  • 39. Antipyretic • Antipyretics are drugs or herbs that reduce fever. • Antipyretics cause the hypothalamus to override an interleukin-induced increase in temperature. • The body then works to lower the temperature, resulting in a reduction in fever. • Most antipyretic medications have other purposes. • The most common antipyretics are ibuprofen and aspirin, which are used primarily as pain relievers. • Non-steroidal anti-inflammatory drugs (NSAIDs) are antipyretic, anti-inflammatory, and pain relievers.